<DOC>
	<DOCNO>NCT01089114</DOCNO>
	<brief_summary>Background : - Antiretroviral therapy increase lifespan people human immunodeficiency virus ( HIV ) , recent research suggest people HIV also increase risk develop cardiovascular disease . To good understand prevalence effect heart disease people HIV , researcher interested compare heart image metabolism study see difference HIV-positive HIV-negative people . Objectives : - To study metabolism heart function people HIV compare healthy HIV-negative volunteer . Eligibility : - Individuals least 18 year age either diagnose HIV healthy HIV-negative volunteer . Design : - Participants evaluate physical exam , detailed medical history , routine blood urine test include HIV testing . - Participants follow image scan : - Cardiac magnetic resonance imaging ( MRI ) study health heart blood vessel - Magnetic resonance spectroscopy ( MRS ) heart , liver , skeletal muscle - Cardiac computerize tomography ( CT ) scan measure calcium level heart nearby artery - Dual-energy x-ray absorptiometry ( DEXA ) scan measure body fat muscle mass . - Stable isotope infusion evaluate body process fat ( require overnight stay test ) - Participants also blood test , echocardiogram , electrocardiogram evaluate heart function ... .</brief_summary>
	<brief_title>Cardiovascular Radiologic Metabolic Assessment HIV : An Investigation Pathophysiology</brief_title>
	<detailed_description>HIV chronic infection patient access antiretroviral therapy significantly improve life expectancy . Patients HIV also increase risk cardiovascular disease . Thus , cardiovascular disease important potential co-morbidity patient live HIV . The current proposal perform detail cardiovascular assessment use state-of-the-art imaging technique evaluate intramyocardial lipid well coronary artery disease myocardial function cohort 100 HIV infect patient 30 healthy volunteer control . This early exploratory cross-sectional study design assess burden disease apply novel technique unique population .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<criteria>HIVInfected Participants Criteria : INCLUSION CRITERIA : 1 . Age 18 year great 2 . Documented HIV infection 3 . Willingness store sample EXCLUSION CRITERIA : 1 . Subject deem unable comply requirement study participation . 2 . Subjects contraindication MRI scanning . These contraindication include limited following device condition : Implanted cardiac pacemaker defibrillator Cochlear implant Ocular foreign body ( e.g . metal shaving ) Embedded shrapnel fragment Central nervous system aneurysm clip Implanted neural stimulator Medical infusion pump Any implant device incompatible MRI . 3 . Subjects require sedation MRI study . 4 . Subjects condition preclude entry scanner acquisition scan ( e.g . morbid obesity , claustrophobia , back pain , motion disorder ) . 5 . Women lactate , pregnant , actively seek become pregnant . 6 . History severe allergic reaction gadolinium contrast agent despite use premedication antihistaminic cortisone . 7 . Estimated glomerular filtration rate ( eGFR ) &lt; 60 cc/min/1.73m ( 2 ) . 8 . Creatinine value &gt; 3.0 mg/dl For Coronary CTA IodineBased Contrast* : 1 . Contraindication use CT contrast agent : Creatinine value &gt; 1.4 mg/dl eGFR &lt; 60 cc/min/1.73m ( 2 ) . History multiple myeloma Use metformincontaining product less 24 hr prior contrast administration History significant allergic reaction CT contrast agent 2 . Subjects contraindication preclude use beta blocker necessary perform coronary CTA . These include : Clinically significant asthma Active bronchospasm Moderate severe chronic obstructive pulmonary disease ( COPD ) 2nd 3rd degree AV block Decompensated cardiac failure Allergy beta blocker Systolic blood pressure &lt; 100 mm Hg 3 . Guidelines use beta blocker outline Appendix 1 . Participants eligible MRI eligible cardiac CT scan allow participate nonCT portion study . Healthy Control Criteria : INCLUSION CRITERIA : 1 . Age 18 year great 2 . Willingness store sample EXCLUSION CRITERIA : All exclusion criterion HIVinfected participant list apply healthy control . In addition , follow exclusion criterion also apply healthy control : 1 . Clinically significant , systemic illness ( serious infection significant cardiac , pulmonary , hepatic , organ dysfunction ) judgment investigator would compromise patient ability tolerate study . 2 . History current know cardiovascular disease . 3 . HIV infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>August 7, 2015</verification_date>
	<keyword>Cardiac Imaging</keyword>
	<keyword>MR Spectroscopy</keyword>
	<keyword>HIV</keyword>
	<keyword>Lipid Metabolism</keyword>
	<keyword>HIV Infection</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>HIV Infections</keyword>
</DOC>